Ignite Creation Date:
2025-12-24 @ 9:28 PM
Ignite Modification Date:
2026-01-20 @ 11:35 AM
Study NCT ID:
NCT02203032
Status:
COMPLETED
Last Update Posted:
2017-09-12
First Post:
2014-07-25
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-10-07
Start Date Type:
ACTUAL
Primary Completion Date:
2015-12-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-05-24
Completion Date Type:
ACTUAL
First Submit Date:
2014-07-25
First Submit QC Date:
None
Study First Post Date:
2014-07-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-06-14
Results First Submit QC Date:
None
Results First Post Date:
2017-07-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-07-14
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-08-11
Last Update Post Date:
2017-09-12
Last Update Post Date Type:
ACTUAL